FSTX - F-star Therapeutics Inc. (FSTX) CEO Eliot Forster on Q3 2021 Results - Earnings Call Transcript
F-star Therapeutics, Inc. (FSTX) Q3 2021 Earnings Conference Call November 10, 2021, 09:00 AM ET Company Participants Lindsey Trickett - VP of IR Eliot Forster - CEO Darlene Deptula-Hicks - CFO Conference Call Participants Hartaj Singh - Oppenheimer & Co. Daina Graybosch - SVB Leerink Justin Walsh - B. Riley Securities Yale Jen - Laidlaw & Company Presentation Operator Good day, and thank you for standing by. Welcome to the F-star Therapeutics Third Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Ms. Lindsey Trickett. Please go ahead, ma'am. Lindsey Trickett Hi. Good morning, everyone. Thank you for joining us. With me today is Eliot Forster, our CEO; and Darlene Deptula-Hicks, our CFO. We announced financial results premarket today for the year ended September 30, 2021. You can access the press release on the Investor Relations page of our
For further details see:
F-star Therapeutics, Inc. (FSTX) CEO Eliot Forster on Q3 2021 Results - Earnings Call Transcript